Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Tripos' ChemSpace available for licensing soon

June 28, 1996

American Biogenetic Sciences obtains antibody technology from MRC

June 28, 1996

Collaboration for oral insulin formulation development

June 28, 1996

Techniclone's TNT to undergo clinical trials

June 28, 1996

Alizyme issued BTG license option

June 28, 1996

Hoechst, Hoechst Marion Roussel and Oncogene Science extend collaboration

June 28, 1996

Oxford Molecular Group and Alizyme begin research collaboration

June 28, 1996

Boston Life Science holds patent rights to C-Maf

June 28, 1996

3-D IMP dehydrogenase structure solved

June 28, 1996

Gensia receives first payment from Pfizer

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...